TREATMENT OF LYMPHATIC MALFORMATIONS IN CHILDREN: 3 YEARS EXPERIENCE
Date Issued
2023-05
Author(s)
Njomza LUMANI-BAKIJI
Lazo JOVCHESKI
Aleksandar STEPANOVSKI
Abstract
Introduction: Lymphatic malformations (LM) are congenital benign malformations from the group of slow-flow vascular anomalies consisting of pathological cystic dilatation of the lymphatic vessels.
The incidence of LM ranges from 1.5 to 2.8% in 2000 to 4000 newborn children, and are relatively rare congenital vascular anomalies. They are characterized with equal representation between
the genders. From the structural aspect, LM are divided into macrocystic, microcystic and mixed type, with its own therapeutic and prognostic implications. A small percentage of LM are combined with additional anomalies and are part of syndromes such as CLOVES, Klippel-Trenaunay, Proteus and others. In recent years, the method of choice in the treatments is sclerosing as a non-invasive method achieving almost excellent results.
The incidence of LM ranges from 1.5 to 2.8% in 2000 to 4000 newborn children, and are relatively rare congenital vascular anomalies. They are characterized with equal representation between
the genders. From the structural aspect, LM are divided into macrocystic, microcystic and mixed type, with its own therapeutic and prognostic implications. A small percentage of LM are combined with additional anomalies and are part of syndromes such as CLOVES, Klippel-Trenaunay, Proteus and others. In recent years, the method of choice in the treatments is sclerosing as a non-invasive method achieving almost excellent results.
File(s)![Thumbnail Image]()
Loading...
Name
Book of Abstracts_Final - Congress 2023.pdf
Size
19 MB
Format
Adobe PDF
Checksum
(MD5):9e93b9c226833b7cd8816fa478aab775